date:Sep 18, 2012
nt of Pediatrics, Division of Neonatology, Foothills Medical Centre in Calgary, Alberta, Canada and colleagues conducted the review and found inosital supplements reduced risk of neonatal death, infant mortality, retinopathy of prematurity, and intraventricular hemorrhage.
For the review, the researchers searched major medical databases in May 2011 including the The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL, Clinicaltrials.gov and Controlled-trials.com and identifi